News AbbVie Acquires Gilgamesh’s Psychedelic MDD Program for up to $1.2BHealthradar26. August 2025 What You Should Know: – AbbVie and Gilgamesh Pharmaceuticals Inc. have announced a definitive agreement for AbbVie to acquire Gilgamesh’s…
